PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Clinical trial NCT00589550 · TERMINATED
Trial details
- NCT number
- NCT00589550
- Sponsor
- Thomas Olencki
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-01-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.